Scancell Hldgs Plc (SCLP)

London
19.50
+0.50(+2.63%)
  • Volume:
    175,924
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    19.20 - 19.20

SCLP Overview

Prev. Close
19
Day's Range
19.2-19.2
Revenue
5.27M
Open
19.5
52 wk Range
10.5-29.4
EPS
-0.01
Volume
175,924
Market Cap
157.09M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,123,354
P/E Ratio
-19.03
Beta
0.639
1-Year Change
13.04%
Shares Outstanding
815,218,831
Next Earnings Date
-
What is your sentiment on Scancell?
or
Market is currently closed. Voting is open during market hours.

Scancell Hldgs Plc News

Scancell Hldgs Plc Company Profile

Scancell Hldgs Plc Company Profile

Scancell Holdings plc is a clinical-stage biopharmaceutical company. The Company is focused on developing immunotherapies for the treatment of cancer and infectious disease. Its technology includes ImmunoBody, GlyMab, Moditope, and AvidiMab. Its products pipeline include SCIB1 & iSCIB1+, SCIB2 & iSCIB2, Modi-1, Modi-2, and SCOV1 and SCOV2 (COVIDITY), as well as Anti-glycan antibodies. Its SCIB1, is developed for the treatment of patients with metastatic melanoma. SCIB1 consists of SCIB1-001 and SCIB1-002. Its SCIB2 is the second cancer vaccine based on the ImmunoBody technology. The SCIB2 & iSCIB2 vaccine is under evaluation for the treatment of patients with solid tumors, including non-small cell lung cancer. Modi-1 is based on Moditope platform, which is composed of a combination of three peptides from two target antigens that are commonly modified in cancer cells. Modi-2 targets homocitrullinated cancer antigens, to address different cancer indications to Modi-1, including tumors.

Read More

Analyst Price Target

Average30.00 (+53.85% Upside)
High30.00
Low30.00
Price19.50
No. of Analysts1
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralNeutralSellStrong SellBuy
Technical IndicatorsBuyStrong BuySellStrong SellStrong Buy
SummaryNeutralBuySellStrong SellStrong Buy
  • how long till SCLP vaccine is on market ?one more year?
    4
    • Market starting to realise that different types of vaccines have value. This company has developed a vaccine that should be a longer term answer...
      0